Sage Therapeutics Inc/ US78667J1088 /
05/07/2024 22:00:00 | Chg. +0.1600 | Volume | Bid00:07:22 | Ask00:07:22 | High | Low |
---|---|---|---|---|---|---|
10.7800USD | +1.51% | 656,449 Turnover: 5.05 mill. |
10.2000Bid Size: 100 | 12.0000Ask Size: 100 | 10.9900 | 10.3000 |
GlobeNewswire
28/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
21/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
12/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
02/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
24/04
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
26/03
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business H...
GlobeNewswire
01/02
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
GlobeNewswire
03/01
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire
14/12/2023
ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is...
GlobeNewswire
02/09/2023
Bragar Eagel & Squire, P.C. Is Investigating DigitalOcean, and Sage and Encourages Investors to Cont...
GlobeNewswire
01/09/2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutic...
GlobeNewswire
28/08/2023
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics (SAGE) Investors with Substant...
GlobeNewswire
28/08/2023
Bragar Eagel & Squire, P.C. Is Investigating Blink, Lovesac, and Sage and Encourages Investors to Co...
GlobeNewswire
23/08/2023
PEOPLE and Great Place To Work® Announce PEOPLE’s “100 Companies that Care” for 2023
GlobeNewswire
21/08/2023
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Sage Therapeutics (SAGE) Investors with Substantial...
GlobeNewswire
20/01/2022
Report: 60% of CIOs Say Tech Budgets are Increasing in 2022 to Improve on Cybersecurity
GlobeNewswire
04/10/2021
Noema Pharma appoints Jeffrey Jonas as Independent Chairman of the Board of Directors
GlobeNewswire
21/09/2021
Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multi...
GlobeNewswire
02/08/2021
Allogene Therapeutics Appoints Industry Leaders Elizabeth (Liz) Barrett and Vicki Sato, Ph.D., to i...